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EDITORIAL COMMENTARY
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Abstract Although measuring creatinine to determine kidney
function is currently the clinical standard, new markers such
as beta-trace protein (BTP) and beta-2-microglobulin (B2M)
are being investigated in an effort to measure glomerular filtration rate more accurately. In their recent publication, Inker
et al. (Am J Kidney Dis 2015; 67:40–48) explored the use of
these two relatively new markers in combination with some
commonly available clinical characteristics in a large cohort of
adults with chronic kidney disease. Their research led them to
develop three formulae using BTP, B2M, and a combination
of the two. The combined formula is particularly attractive as
it removes all gender bias, which applies to both serum creatinine and cystatin C. Using data from a cohort of 127 pediatric
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patients from our center, we sought to determine whether
these formulae would be equally as effective in children as
in adults. Unfortunately, we found that the formulae cannot be
applied to the pediatric population.
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Introduction
In a recent edition of the American Journal of Kidney
Diseases, Inker et al. explore the role of the unconventional
endogenous filtration markers beta-trace protein (BTP) and
beta-2 microglobulin (B2M) in estimating glomerular filtration rate (GFR) [1]. Using data from 3551 subjects in three
large adult populations with chronic kidney disease (CKD),
they developed and validated a robust formula to estimate
GFR using these biomarkers and commonly available clinical
characteristics. Inker et al.’s study [1] carefully adjusted for
covariates such as gender, ethnicity, and age. We were particularly interested in the fact that there was no bias induced by
gender. There is a significant difference in body fat between
the genders during puberty [2]. An adjustment for gender must
be made in order to accurately estimate GFR in children when
using creatinine [2, 3], cystatin C [4], and BTP [2, 5]. A
formula that would be independent of gender would greatly
improve the practice of estimating GFR in children.
Unfortunately, the mean age of the relatively homogenous
patient population in Inker et al.’s study was 54.0 ± 22.7 years,
with relatively few young adults and no children. It should be
noted that each formula works best in the population type and
within the GFR range in which it was generated [6].
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Table 1 Chronic Kidney Disease Epidemiology Collaboration
equations for the estimation of glomerular filtration rate based on the
endogenous filtration markers beta-trace protein and beta-2 microglobulin alone and in combination
CKD-EPI equations [1]

Formulae

BTP

GFR = 55 x BTP−0.695 × 0.998age
x 0.899 if female

B2M
BTP-B2M

GFR = 133 × B2M−0.852
GFR = 96 × BTP−0.278 × B2M−0.588

CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; BTP,
beta-trace protein; B2M, beta-2-microglobulin; GFR, glomerular filtration rate

median B2M concentration was 1.93 (IQR 1.52–2.69) mg/L.
The mean measured 51Cr-EDTA-GFR was 100.6 ± 32.1 ml/
min/1.73 m2 compared to a BTP-eGFR of 61.93 ± 14.11 ml/
min/1.73 m2, a B2M-eGFR of 76.95 ± 31.93 ml/min/1.73 m2,
and a BTP-B2M-eGFR of 70.13 ± 23.52 ml/min/1.73 m2,
whereas the absolute measured GFR was 75.27 ± 31.09 ml/
min. As such, the results are only comparable to the absolute
(non-adjusted to body surface area) GFR. While all three new
eGFR results significantly correlated with the absolute GFR,
the Pearson R2 values were <0.3 (Table 2). Bland & Altman
analysis of the unadjusted absolute GFR with the combined
BTP-B2M-based eGFR formula revealed a bias of −5.151 ±
27.06 ml/min with a 95 % confidence interval between −58.19
and +47.90 ml/min (Fig. 1).

The Inker formulae
Conclusions
To study the usability of the new Inker formulae in children and
adolescents, we applied the formulae using a post-hoc analysis of
previously published data [7]. A total of 127 pediatric patients
with various renal diseases underwent simultaneous measurements of GFR using a 51Cr-ethylenediaminetetraacetic acid
(EDTA) renal scan, BTP and B2M, as outlined in our previous
publication [7]. The median age was 11.9 [interquartile range
(IQR) 8.5–14.9] years and the mean 51Cr-EDTA GFR was
100.6 ± 32.1 ml/min/1.73 m2, which was significantly higher
than that of Inker et al.’s pooled population [1]. GFR distribution
was normal (Kolmogorov–Smirnov test) and, as such, a linear
regression analysis was used to assess the relationship between
the calculated estimated GFR (eGFR) and the measured GFR.
The agreement of the various formulae was assessed using the
Bland & Altman analysis. All statistical tests were performed
using GraphPadPrism 5.0f for Mac (GraphPad Software Inc.,
La Jolla, CA). The formulae for BTP, B2M and BTP-B2M combined are listed in Table 1.
BTP and B2M were not normally distributed. The median
BTP concentration was 0.76 (IQR 0.62–0.98) mg/L, and the
Table 2 Linear regression
analysis of the measured
unadjusted glomerular filtration
rate for body surface area and the
CKD-EPI equations from Table 1

While the bias of the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) BTP-B2M-based eGFR formula
was acceptable in this pediatric cohort, small, and similar to
that observed in the training and validation cohort, the 95 %
confidence interval was unacceptable. However, it is possible
that including B2M can reduce the effect of gender. Cystatin C
is produced by all nucleated cells in the body with the exception of adipocytes [8]. The volume of distribution of cystatin C
is most likely the extracellular volume (ECV), which correlates better with lean body mass than body surface area [9].
While BTP is produced in the coronary arteries (reviewed
recently by Filler et al. [10], the differing fat mass between
the genders has been shown to affect BTP-based GFR estimates [2]. Its volume of distribution is unknown [10]. B2M is
a component of MHC class I molecules, which are present on
all nucleated cells. Its volume of distribution is also considered
to be the ECV [11], which suggests body fat mass should
affect its use in estimating GFR. Interestingly, Inker et al.
found that including gender in B2M-based GFR estimation

Linear regressio analysis

BTP-GFR

B2M-GFR

BTP-B2M-GFR

Best-fit values
Slope

0.2371 ± 0.03460

0.4849 ± 0.08067

0.4072 ± 0.05703

43.53 ± 2.816
−183.6
4.217
0.2731
<0.0001
Significant

40.45 ± 6.566
−83.40
2.062
0.2243
<0.0001
Significant

39.48 ± 4.642
−96.96
2.456
0.2897
<0.0001
Significant

127
0

127
0

127
0

Y-intercept when X = 0.0
X-intercept when Y = 0.0
1/slope
R2
P value
Deviation from zero?
Data
Total number of values
Number of missing values

BTP beta trace protein, B2M beta-2-microglobulin, GFR glomerular filtration rate, CKD chronic kidney disease
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Fig. 1 Bland & Altman analysis of the absolute glomerular filtration rate
(GFR) (unadjusted for body surface area) of 127 children and adolescents
with the new beta trace protein-beta-2 microglobulin-estimated GFR
(BTP-B2M eGFR) formula by Inker et al. [1]. SD Standard deviation

did not improve results. This phenomenon should be subject
to additional study. Following our analysis, we conclude that
the new CKD-EPI BTP-B2M-based eGFR formula cannot be
used in children.
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